Abstract
Background Implantable telemetric intracranial pressure sensors (telesensors) enable routine, non-invasive ICP feedback, aiding clinical decision-making and attribution of pressure-related symptoms in patients with CSF shunt systems. Here, we aim to explore the impact of these devices on service demand and costs in patients with adult hydrocephalus.
Methods We performed an observational propensity matched control study, comparing all patients who had an MScio/Sensor Reservoir (Christoph Mietke, GmbH & Co) against those with a non-telemetric reservoir between March 2016 and March 2018. Patients were matched based on demographics, diagnosis, shunt-type and revision status. Neurosurgical service usage was recorded with frequencies of neurosurgical admissions, outpatient clinics, scans and further surgical procedures in the two years prior and after shunt insertion.
Results 136 patients: 73 telesensor and 63 controls were included in this study (48 matched pairs). Telesensor use led to a significant decrease in neurosurgical inpatient admissions, radiographic encounters and further procedures such as intracranial pressure monitoring. After multivariate adjustment, the mean cumulative saving after two years was £5236 ($6338) in telesensor patients (£5498 on matched pair analysis). On break-even analysis, cost-savings were likely to be achieved within 8 months of clinical use, post-implantation. Telesensor patients also experienced a significant reduction in imaging-associated radiation (4 mSv) over two years.
Conclusions The findings of this exploratory study reveal that telesensor implantation is associated with reduced service demand and provides net financial savings from an institutional perspective. Moreover, telesensor patients required fewer appointments, invasive procedures, and had less radiation exposure, indicating an improvement in both their experience and safety.
What is already known on this topic – Despite shunt insertion being one of the most common treatments for adult hydrocephalus, there is a lack of research concerning the economic viability of shunt components. This includes newer devices such as telemetric sensor reservoirs (telesensors) which can measure intracranial pressure non-invasively, and are posited to have various clinical benefits, but have a greater base cost.
What this study adds – To the best of our knowledge, this is the first matched case-control study evaluating the service demands associated with telesensor use in the largest cohort of this group worldwide. It provides compelling evidence that the integration of telesensors in a diverse set of adult hydrocephalus patients with CSF shunt systems yields noteworthy reductions in service demands, cost and radiation exposure as compared to non-telemetric alternatives.
How this study might affect research, practice or policy – The results of this study will encourage further confirmatory research in financial utility analysis in adult hydrocephalus. It will likely influence practice in supporting a healthcare business model for greater telesensor use.
Competing Interest Statement
Funding: A.K.T is supported by the NIHR UCLH Biomedical Research Centre, E.M.M. is supported by BBraun. None of the funding sources influenced the design, analysis or reporting of the study. Conflicts of interest: The authors have no conflicts of interest to declare.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board (Queen Square Quality and Safety Committee) approved this study (122-202021-CA), conducted within the context of a service evaluation in the use of telesensor devices at our centre.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: A.K.T is supported by the NIHR UCLH Biomedical Research Centre, E.M.M. is supported by BBraun. None of the funding sources influenced the design, analysis or reporting of the study.
Conflicts of interest: The authors have no conflicts of interest to declare.
Data Availability
All data produced in the present study are available upon reasonable request to the authors, providing ethical permissions have been obtained